145 related articles for article (PubMed ID: 26333571)
21. Detection of HIV-1 matrix protein p17 in sera of viremic and aviremic patients.
Zani A; Messali S; Uggeri M; Bonfanti C; Caruso A; Caccuri F
J Virol Methods; 2024 Feb; 324():114858. PubMed ID: 38029970
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 matrix protein p17 binds to monocytes and selectively stimulates MCP-1 secretion: role of transcriptional factor AP-1.
Marini E; Tiberio L; Caracciolo S; Tosti G; Guzman CA; Schiaffonati L; Fiorentini S; Caruso A
Cell Microbiol; 2008 Mar; 10(3):655-66. PubMed ID: 18042260
[TBL] [Abstract][Full Text] [Related]
23. Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin.
Caccuri F; D'Ursi P; Uggeri M; Bugatti A; Mazzuca P; Zani A; Filippini F; Salmona M; Ribatti D; Slevin M; Orro A; Lu W; Liò P; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33372148
[TBL] [Abstract][Full Text] [Related]
24. A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity.
Giagulli C; Caccuri F; Cignarella F; Lougaris V; Martorelli D; Bugatti A; Rusnati M; Dolcetti R; Vitali M; Plebani A; Fiorentini S; Caruso A
AIDS; 2014 Oct; 28(16):2355-64. PubMed ID: 25121556
[TBL] [Abstract][Full Text] [Related]
25. High expression of HIV-1 matrix protein p17 in both lymphoma and lymph node tissues of AIDS patients.
Feng Y; Wang Z; Zeng D; Song S; Yang Y; Wang A; Xu J; Guo W; Wu M; Shi Y; Zheng Y; Li D; Zhang R; Lu H
Pathol Res Pract; 2022 Sep; 237():154061. PubMed ID: 35939971
[TBL] [Abstract][Full Text] [Related]
26. The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.
Li S; Bozzo L; Wu Z; Lu W; Romerio F
New Microbiol; 2010 Jan; 33(1):13-24. PubMed ID: 20402410
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 matrix protein p17 increases the production of proinflammatory cytokines and counteracts IL-4 activity by binding to a cellular receptor.
De Francesco MA; Baronio M; Fiorentini S; Signorini C; Bonfanti C; Poiesi C; Popovic M; Grassi M; Garrafa E; Bozzo L; Lewis GK; Licenziati S; Gallo RC; Caruso A
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9972-7. PubMed ID: 12105273
[TBL] [Abstract][Full Text] [Related]
28. Identification of amino acid residues critical for the B cell growth-promoting activity of HIV-1 matrix protein p17 variants.
He W; Mazzuca P; Yuan W; Varney K; Bugatti A; Cagnotto A; Giagulli C; Rusnati M; Marsico S; Diomede L; Salmona M; Caruso A; Lu W; Caccuri F
Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):13-24. PubMed ID: 30248376
[TBL] [Abstract][Full Text] [Related]
29. HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation.
Giagulli C; Magiera AK; Bugatti A; Caccuri F; Marsico S; Rusnati M; Vermi W; Fiorentini S; Caruso A
Blood; 2012 Mar; 119(10):2274-83. PubMed ID: 22262769
[TBL] [Abstract][Full Text] [Related]
30. A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: implications for EBV-driven lymphomagenesis in the HIV setting.
Martorelli D; Muraro E; Mastorci K; Dal Col J; Faè DA; Furlan C; Giagulli C; Caccuri F; Rusnati M; Fiorentini S; Carbone A; Caruso A; Dolcetti R
Int J Cancer; 2015 Sep; 137(6):1374-85. PubMed ID: 25704763
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells.
Poiesi C; De Francesco MA; Baronio M; Manca N
Virus Res; 2008 Mar; 132(1-2):25-32. PubMed ID: 18036696
[TBL] [Abstract][Full Text] [Related]
32. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
[TBL] [Abstract][Full Text] [Related]
33. Characterization of mother-infant HIV type 1 gag p17 sequences associated with perinatal transmission.
Hahn T; Matala E; Chappey C; Ahmad N
AIDS Res Hum Retroviruses; 1999 Jul; 15(10):875-88. PubMed ID: 10408724
[TBL] [Abstract][Full Text] [Related]
34. Synthetic HIV-1 matrix protein p17-based AT20-KLH therapeutic immunization in HIV-1-infected patients receiving antiretroviral treatment: A phase I safety and immunogenicity study.
Iaria ML; Fiorentini S; Focà E; Zicari S; Giagulli C; Caccuri F; Francisci D; Di Perri G; Castelli F; Baldelli F; Caruso A
Vaccine; 2014 Feb; 32(9):1072-8. PubMed ID: 24456624
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 matrix protein p17 resides in cell nuclei in association with genomic RNA.
Bukrinskaya AG; Vorkunova GK; Tentsov YYu
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1795-801. PubMed ID: 1457192
[TBL] [Abstract][Full Text] [Related]
37. Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion.
Sato A; Yoshimoto J; Isaka Y; Miki S; Suyama A; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1996 Jun; 220(1):208-12. PubMed ID: 8659115
[TBL] [Abstract][Full Text] [Related]
38. Calmodulin and HIV type 1: interactions with Gag and Gag products.
Radding W; Williams JP; McKenna MA; Tummala R; Hunter E; Tytler EM; McDonald JM
AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1519-25. PubMed ID: 11054265
[TBL] [Abstract][Full Text] [Related]
39. Functions of the HIV-1 matrix protein p17.
Fiorentini S; Marini E; Caracciolo S; Caruso A
New Microbiol; 2006 Jan; 29(1):1-10. PubMed ID: 16608119
[TBL] [Abstract][Full Text] [Related]
40. HIV p17 enhances T cell proliferation by suppressing autophagy through the p17-OLA1-GSK3β axis under nutrient starvation.
Lu J; Jia J; Zhang J; Liu X
J Med Virol; 2021 Jun; 93(6):3607-3620. PubMed ID: 32790080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
